Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds

Shock

Volumn 12, Issue 3, 1999, Pages 174-180

  Hoffmann, Johannes N ^a   Werdan, Karl ^b   Hartl, Wolfgang H ^a   Jochum, Marianne ^a   Faist, Eugen ^a   Inthorn, Dietrich ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; CYTOKINE;

ADULT; ANIMAL; ARTICLE; BLOOD; CASE CONTROL STUDY; CELL CULTURE; ELECTROSTIMULATION; FEMALE; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEMOFILTRATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SEPSIS;

ADULT; ANIMALS; CASE-CONTROL STUDIES; CELLS, CULTURED; COMPLEMENT C3A; COMPLEMENT C5A; CYTOKINES; ELECTRIC STIMULATION; FEMALE; HEMOFILTRATION; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; RATS; SEPSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033190680     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199909000-00002     Document Type: Article

References (38)

1. Vincent JL, Gris P, Coffernils M, Leon M, Pinsky M, Reuse C, Kahn RJ: Myocardial depression characterizes the fatal course of septic shock. Surgery 111:660-667, 1992.
2. Parker MM, McCarthy KE, Ognibene FP, Parrillo JE: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97:126-131, 1990.
3. Parrillo JE: The cardiovascular pathophysiology of sepsis. Ann Rev Med 40:469-485, 1989.
4. Mueller-Werdan U, Reithmann C, Werdan K: Cytokines and the heart: molecular mechanisms of septic cardiomyopathy. Austin, TX: RG Landes Company, 1996.
5. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W: A circulating myocardial depressant substance in humans with septic shock: Septic shock patients with a reduced ejection fraction have a cir-culating factor which depresses in vitro myocardial cell performance. J Clin Invest 76:1539-1553, 1985.
6. Hörl WH, Riegel W: Cardiac depressant factors in renal disease. Circulation 87:IV, 77-82, 1993.
7. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477, 1993
8. Bone RC: The pathogenesis of sepsis. Ann Int Med 115:457-469, 1991.
9. Granton JT, Goddard CM, Allard MF, van Eeden S, Walley KR: Leukocytes and decreased left-ventricular contractility during endotoxinemia in rabbits. Am J Respir Crit Care Med 155:1977-1983, 1997.
10. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF: Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte adrenergic responsiveness. Proc Natl Acad Sci USA 86:6753-6757, 1989.
11. Balligand J, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW: Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiomyocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91:2314-2319, 1993.
12. Reithmann C, Hallström S, Pilz G, Kapsner T, Schlag G, Werdan K: Desensitization of rat cardiomyocyte adenylyl cyclase stimulation by plasma of noradrenaline-treated patients with septic shock. Circ Shock 41:48-59, 1993.
13. Kumar A, Venkateswarlu T, Dee L, Olson J, Uretz E, Parrillo JE: Tumor necrosis factor a and interleukin 1 β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183:949-958, 1996.
14. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Tumor necrosis factor and cardiac function. Science 257:387-389, 1992.
15. Weisensee D, Bereiter-Hahn J, Schoeppe W, Löw-Friedrich J. Effects of cytokines on the contractility of cultured cardiac myocytes. Int J Immunopharmac 15:581-587, 1993.
16. Abraham E, Raffin TA: Sepsis therapy trials: continued disappointment or reason for hope? JAMA 271:1876-1878, 1994.
17. Werdan K: Towards a more causal treatment of septic cardiomyopathy. In Vincent JL (ed): Yearbook of intensive care and emergency medicine. Berlin Heidelberg: Springer Verlag, 1995, pp 518-538.
18. Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D: Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22: 1360-1367, 1996.
19. Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D: Hemofiltration in human sepsis: evidence for the elimination of immunomodulatory substances. Kidney Int 48:1563-1570, 1995.
20. Werdan K, Erdmann E: Preparation and culture of embryonic and neonatal heart muscle cells: Modification of transport activity. Meth Enzymol 173: 634-662, 1989.
21. Mueller-Werdan U, Schumann H, Loppnow H, Fuchs R, Darmer D, Stadler J, Holtz J, Werdan K: Endotoxin and tumor necrosis factor a exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles. J Mol Cell Cardiol 30:1027-1036, 1998.
22. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/ tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105, 1986.
23. Hoffmann JN, Hartl WH, Faist E, Jochum M, Inthorn D: Tumor necrosis factor measurement and use of different anticoagulants: Possible interferences in plasma samples and supernatants from endotoxin-stimulated monocytes. Inflamm Res 46:342-347, 1997.
24. Eskandari MK, Nguyen DT, Kunkel SL, Remick DG: WEHI subclone 13 assay for TNF: sensitivity, specificity, and reliability. Immunol Invest 19(1):69-79, 1990.
25. Storck M, Hartl WH, Zimmerer E, Inthorn D: Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 337:452-455, 1991.
26. Gomez A, Wang R, Unruh H, Light RB, Bose D, Chau T, Correa E, Mink S: Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 73:671-685, 1990.
27. van Bommel EFH, Grootendorst AF, van Leengoed LAMG: The influence of high volume hemofiltration on hemodynamics in porcine endotoxic shock. Blood Purif 10:88-89, 1992.
28. Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18:235-240, 1992.
29. Grootendorst AF, van Bommel EFH, van Leengoed LAMG, Nabuurs M, Bouman CSC, Groeneveld ABJ: High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 2:72-78, 1994.
30. Coraim F, Trubel W, Ebermann R, Werner T: Isolation of low-molecular-weight peptides in hemofiltrated patients with cardiogenic shock: a new aspect of myocardial depressant substances. Contrib Nephrol 93:237-240, 1991.
31. Grootendorst AF, van Bommel EFH, van Leengoed LAMG, van Zanten ARH, Huipen HJC, Groeneveld ABJ: Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 8:161-169, 1993.
32. Lee PA, Matson JR, Pryor RW, Hinshaw LB: Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 21:914-924, 1993.
33. Göhl H, Konstantin P: Membranes and Filters for Hemofiltration. In Henderson LW, Quellhorst EA, Baldamus CA, Lysaght MJ (eds): Hemofiltration. Berlin, Heidelberg, New York, Tokyo: Springer-Verlag, 1986, pp 41-82.
34. Müller Werdan U, Klein D, Zander M, Werdan K, Hammer C: Beating neonatal rat cardiomyocytes as a model to study the role of xenoreactive natural antibodies in xenotransplantation. Transplantation 58:1403-1409, 1994.
35. Hallström S, Koidl B, Müller U, Werdan K, Schlag G: A cardiodepressant factor isolated from blood blocks Ca current in cardiomyocytes. Am J Physiol 260:H 869-H 876, 1991.
36. Hallström S, Bernhardt E, Müller U, Fürst W, Vogl C, Koidl B, Werdan K, Schlag G: A cardiodepressant factor (CDF) isolated from hemofiltrates of patients and/ or in cardiogenic shock blocks calcium inward current in cardiomyocytes. Shock 2:S15(Abstr), 1994.
37. Honore PM, Jamez J, Wauthier M: Improved survival with short time high-volume hemofiltration in patients with refractory shock. Intensive Care Med 23:811 (Abstr), 1997.
38. Tetta C, Camussi G, Turello E, Salomone M, Aimo G, Priolo G, Segoloni G, Vercellone A: Production of cytokines in hemodialysis. Blood Purif 8:337-346, 1990.